RNA aptamers selected against DNA polymerase β inhibit the polymerase activities of DNA polymerases β and κ
暂无分享,去创建一个
Arthur P. Grollman | Holly Miller | A. Grollman | L. Gening | H. Miller | Leonid V. Gening | Svetlana A. Klincheva | Anastasia Reshetnjak | S. A. Klincheva | Anastasia Reshetnjak
[1] L. Gold,et al. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. , 1996, Journal of molecular biology.
[2] H. Miller,et al. Kinetics of DNA polymerase I (Klenow fragment exo-) activity on damaged DNA templates: effect of proximal and distal template damage on DNA synthesis. , 1997, Biochemistry.
[3] S. H. Wilson,et al. Short gap-filling synthesis by DNA polymerase beta is processive. , 1993, The Journal of biological chemistry.
[4] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[5] D. H. Burke,et al. Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli. , 2003, RNA.
[6] F. Hanaoka,et al. Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. , 2000, Genes & development.
[7] T. Kunkel,et al. The Y-family of DNA polymerases. , 2001, Molecular cell.
[8] S. Benkovic,et al. Kinetic characterization of the polymerase and exonuclease activities of the gene 43 protein of bacteriophage T4. , 1992, Biochemistry.
[9] Vadim Nikiforov,et al. Aptamers to Escherichia coli core RNA polymerase that sense its interaction with rifampicin, sigma-subunit and GreB. , 2004, European journal of biochemistry.
[10] R. Jenison,et al. A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX). , 1999, Combinatorial chemistry & high throughput screening.
[11] Rodrigo Lopez,et al. Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..
[12] C. Carles,et al. Selective Targeting and Inhibition of Yeast RNA Polymerase II by RNA Aptamers* , 1997, The Journal of Biological Chemistry.
[13] V. Prasad,et al. Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment) , 2002, Journal of Virology.
[14] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[15] R. Woodgate,et al. Snapshots of replication through an abasic lesion; structural basis for base substitutions and frameshifts. , 2004, Molecular cell.
[16] F. Hanaoka,et al. A Role for DNA Polymerase β in Mutagenic UV Lesion Bypass* , 2002, The Journal of Biological Chemistry.
[17] L. Gold,et al. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.
[18] V. Prasad,et al. Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals. , 2003, Current drug targets. Infectious disorders.
[19] D. Patel,et al. Adaptive recognition by nucleic acid aptamers. , 2000, Science.
[20] L. Loeb,et al. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. , 2002, Cancer research.
[21] T. Steitz,et al. The structure of HIV‐1 reverse transcriptase complexed with an RNA pseudoknot inhibitor , 1998, The EMBO journal.
[22] Holly Miller,et al. The murine DNA glycosylase NEIL2 (mNEIL2) and human DNA polymerase beta bind microtubules in situ and in vitro. , 2005, DNA repair.
[23] J. Sweasy,et al. The D246V mutant of DNA polymerase beta misincorporates nucleotides: evidence for a role for the flexible loop in DNA positioning within the active site. , 2004, The Journal of biological chemistry.
[24] V. Bergoglio,et al. Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: impact on sensitivity towards antitumor agents , 2001, Oncogene.
[25] Samuel H. Wilson,et al. Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. , 1997, Biochemistry.
[26] A D Ellington,et al. In vitro selection of nucleic acid aptamers that bind proteins. , 1996, Methods in enzymology.
[27] Sean J. Johnson,et al. Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] Jack A. Taylor,et al. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. , 2002, Cancer research.
[29] Y. Canitrot,et al. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Steinhoff,et al. HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity* , 2000, The Journal of Biological Chemistry.
[31] S. Benkovic,et al. Kinetic mechanism of DNA polymerase I (Klenow). , 1987, Biochemistry.
[32] K Morikawa,et al. Synthetic Activity of Sso DNA Polymerase Y1, an Archaeal DinB-like DNA Polymerase, Is Stimulated by Processivity Factors Proliferating Cell Nuclear Antigen and Replication Factor C* , 2001, The Journal of Biological Chemistry.
[33] S. H. Wilson,et al. Expression of human DNA polymerase beta in Escherichia coli and characterization of the recombinant enzyme. , 1988, Biochemistry.
[34] L. Gold,et al. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[36] F. Hanaoka,et al. A role for DNA polymerase beta in mutagenic UV lesion bypass. , 2002, Journal of Biological Chemistry.
[37] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[38] D. H. Burke,et al. HIV-1 inactivation by nucleic acid aptamers. , 2006, Frontiers in bioscience : a journal and virtual library.
[39] S. H. Wilson,et al. 8-oxodGTP incorporation by DNA polymerase beta is modified by active-site residue Asn279. , 2000, Biochemistry.
[40] S. H. Wilson,et al. Mammalian base excision repair and DNA polymerase beta. , 1998, Mutation research.
[41] C. Kisker,et al. Lesion (in)tolerance reveals insights into DNA replication fidelity , 2004, The EMBO journal.
[42] C. Ng,et al. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation. , 2001, Anticancer research.
[43] W. Beard,et al. Specific inhibition of DNA polymerase beta by its 14 kDa domain: role of single- and double-stranded DNA binding and 5'-phosphate recognition. , 1995, Nucleic acids research.
[44] L. Loeb,et al. Deregulated DNA polymerase β induces chromosome instability and tumorigenesis , 2002 .
[45] Georg Sczakiel,et al. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. , 2002, Nucleic acids research.
[46] R. Woodgate. A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.
[47] J. Sabina,et al. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. , 1999, Journal of molecular biology.
[48] S. Benkovic,et al. Kinetic mechanism of DNA polymerase I , 1987 .
[49] A D Ellington,et al. Toward Automated Nucleic Acid Enzyme Selection , 2001, Biological chemistry.
[50] M. Albertella,et al. The overexpression of specialized DNA polymerases in cancer. , 2005, DNA repair.
[51] X. Zhong,et al. DNA polymerase beta: pre-steady-state kinetic analysis and roles of arginine-283 in catalysis and fidelity. , 1996, Biochemistry.
[52] S. Banerjee,et al. Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines. , 2002, Gene expression.